Zhengping Wu

409 citations
11 papers · 306 indexed · h-index 6
Co-authors
Jie ZhouXi ChenChi-Ming LiuBaojian WuYi WangDanyi LuZhigang WangDong Dong
Topics
MicroRNA in disease regulation (3 papers)Ferroptosis and cancer prognosis (3 papers)Cancer-related molecular mechanisms research (2 papers)
Partner nations
China

In The Last Decade

Zhengping Wu

10 papers receiving 303 citations

Peers

Zhengping Wu
Comparison fields: 5 of 64
  • Complementary and alternative medicine 167
  • Molecular Biology 144
  • Pharmacology 47
  • Cancer Research 44
  • Pulmonary and Respiratory Medicine 43
Replace Feihai Shen with:
Feihai Shen China
Yongfeng Jia China
Guo Zhu-ying China
Siyue Lou China
Jiajun Liu China
Donglu Wu China
Fengna Yan China
Dong-Jun Lin China
Zhengping Wu relative to Feihai Shen China Feihai Shen's profile →
Citations per field
00.5×2.5×
Feihai Shen · 1×
Citations per year

Countries citing papers authored by Zhengping Wu

Since Specialization
Citations

This map shows the geographic impact of Zhengping Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhengping Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhengping Wu more than expected).

Fields of papers citing papers by Zhengping Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhengping Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhengping Wu. The network helps show where Zhengping Wu may publish in the future.

Co-authorship network of co-authors of Zhengping Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhengping Wu. A scholar is included among the top collaborators of Zhengping Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhengping Wu. Zhengping Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 0
2 1
3 14
4 30
5 20
6 4
7 10
8 10
9 5
10 211
11
Advance in Pharmacological Research for Saikosaponin
1

About Zhengping Wu

Zhengping Wu is a scholar working on Cancer Research, Complementary and alternative medicine and Endocrine and Autonomic Systems, having authored 11 papers that have together received 306 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), Ferroptosis and cancer prognosis (3 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Complementary and alternative medicine (167 citations), Pharmacology (47 citations) and Cancer Research (44 citations). Zhengping Wu has collaborated with scholars based in China. Frequent co-authors include Jie Zhou, Xi Chen, Chi-Ming Liu, Baojian Wu, Yi Wang, Danyi Lu, Zhigang Wang, Dong Dong, Pei Yu and Dong Dong. Their work appears in journals such as Journal of Agricultural and Food Chemistry, Biochemical Pharmacology and Frontiers in Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026